What is Dostarlimab: Uses, Dosage, Side Effects and More

Dostarlimab is a cutting-edge cancer treatment that helps your immune system fight certain types of cancer more effectively. It's a targeted therapy called an immunotherapy drug that works by removing the brakes on your body's natural cancer-fighting cells, allowing them to attack tumors more aggressively.

This medication represents a significant advancement in cancer care, offering hope for patients with specific types of cancer that haven't responded well to traditional treatments. Understanding how dostarlimab works and what to expect can help you feel more prepared and confident about your treatment journey.

What is Dostarlimab?

Dostarlimab is a prescription immunotherapy medication that belongs to a class of drugs called PD-1 inhibitors. It's designed to help your immune system recognize and attack cancer cells that have been hiding from your body's natural defenses.

Think of your immune system like a security team that patrols your body looking for threats. Cancer cells are clever and can disguise themselves to avoid detection. Dostarlimab works by removing these disguises, making it easier for your immune system to spot and destroy the cancer cells.

The drug is administered through an intravenous infusion, meaning it's delivered directly into your bloodstream through a vein. This method ensures the medication reaches cancer cells throughout your body effectively.

What is Dostarlimab Used For?

Dostarlimab is primarily used to treat advanced endometrial cancer that has spread beyond the uterus or returned after previous treatment. It's specifically approved for cancers that have certain genetic characteristics called mismatch repair deficiency or microsatellite instability-high.

Your doctor will test your cancer tissue to determine if it has these specific genetic markers before recommending dostarlimab. This personalized approach helps ensure you receive the most effective treatment for your particular type of cancer.

In some cases, dostarlimab may also be used for other types of solid tumors that have these same genetic characteristics. Your oncologist will carefully evaluate whether this medication is right for your specific situation.

How Does Dostarlimab Work?

Dostarlimab works by blocking a protein called PD-1 on your immune cells. This protein normally acts like a brake pedal, preventing your immune system from attacking healthy cells by mistake.

Cancer cells exploit this safety mechanism by sending signals that activate these brakes, essentially telling your immune system to leave them alone. Dostarlimab blocks these brake signals, allowing your T-cells (a type of white blood cell) to recognize and attack the cancer.

This medication is considered a strong and effective treatment option. Unlike chemotherapy, which directly attacks cancer cells, dostarlimab empowers your own immune system to do the fighting. This approach can lead to longer-lasting responses in some patients.

How Should I Take Dostarlimab?

Dostarlimab is given as an intravenous infusion in a medical facility, typically a hospital or cancer treatment center. You cannot take this medication at home, as it requires careful monitoring by healthcare professionals.

The infusion usually takes about 30 minutes to complete. Your healthcare team will insert a small tube called an IV catheter into a vein in your arm or hand. The medication will then flow slowly into your bloodstream.

Before your infusion, you may receive pre-medications to help prevent allergic reactions. These might include antihistamines or steroids. You don't need to avoid food before treatment, but staying well-hydrated by drinking plenty of water is helpful.

Plan to spend a few hours at the treatment center, as you'll need to be monitored for any immediate reactions during and after the infusion. Most patients can resume normal activities the same day, though some may feel tired.

How Long Should I Take Dostarlimab For?

The duration of dostarlimab treatment varies significantly from person to person, depending on how well the cancer responds and how you tolerate the medication. Some patients may receive treatment for several months, while others may continue for a year or longer.

Your oncologist will regularly monitor your cancer's response through imaging scans and blood tests. Treatment typically continues as long as the cancer is responding well and you're not experiencing severe side effects.

If your cancer progresses or you develop serious side effects, your doctor may need to adjust your treatment plan. The goal is to find the right balance between fighting the cancer effectively and maintaining your quality of life.

What Are the Side Effects of Dostarlimab?

Like all powerful medications, dostarlimab can cause side effects, though not everyone experiences them. Understanding what to watch for can help you and your healthcare team manage any issues that arise.

Here are the most common side effects you might experience during treatment:

• Fatigue and feeling more tired than usual
• Nausea and occasional vomiting
• Diarrhea or changes in bowel movements
• Decreased appetite
• Muscle or joint aches
• Skin rash or itching
• Fever or chills

These common side effects are usually manageable with supportive care and medications. Your healthcare team will provide strategies to help you cope with these symptoms.

More serious but less common side effects can occur when your immune system becomes overactive and attacks healthy parts of your body. These immune-related side effects require immediate medical attention:

• Severe diarrhea or abdominal pain (colitis)
• Persistent cough or shortness of breath (pneumonitis)
• Unusual fatigue or yellowing of skin (hepatitis)
• Excessive thirst or urination (diabetes)
• Severe headaches or vision changes (brain inflammation)
• Persistent muscle weakness or numbness

While these serious side effects are rare, occurring in less than 10% of patients, they can be life-threatening if not treated promptly. Your healthcare team will monitor you closely and provide clear instructions on when to contact them immediately.

Who Should Not Take Dostarlimab?

Dostarlimab isn't suitable for everyone, and your doctor will carefully evaluate whether it's safe for you. People with certain medical conditions or circumstances may not be able to receive this treatment.

You should not receive dostarlimab if you have a known severe allergic reaction to this medication or any of its ingredients. Your doctor will review your allergy history before starting treatment.

Special caution is needed if you have autoimmune diseases like rheumatoid arthritis, lupus, or inflammatory bowel disease. Since dostarlimab stimulates your immune system, it could potentially worsen these conditions.

If you're pregnant or breastfeeding, dostarlimab is not recommended as it could harm your baby. Women of childbearing age should use effective contraception during treatment and for several months after the last dose.

People with active infections or those who have received organ transplants may also not be suitable candidates for this treatment. Your doctor will consider your complete medical history before making treatment recommendations.

Dostarlimab Brand Names

Dostarlimab is available under the brand name Jemperli in the United States and many other countries. This is the only currently approved brand name for this medication.

When discussing your treatment with healthcare providers or insurance companies, you may hear both names used interchangeably. They refer to the same medication with the same active ingredient.

Always verify with your healthcare team that you're receiving the correct medication, especially if you're treated at different facilities or by different doctors.

Dostarlimab Alternatives

Several other immunotherapy medications work similarly to dostarlimab and might be options depending on your specific type of cancer. These include pembrolizumab (Keytruda) and nivolumab (Opdivo), which are also PD-1 inhibitors.

The choice between these medications depends on factors like your specific cancer type, genetic markers, previous treatments, and overall health. Your oncologist will consider all these factors when determining the best treatment approach.

Traditional treatment options like chemotherapy, radiation therapy, or surgery might also be considered either instead of or in combination with immunotherapy. The best treatment plan is highly individualized based on your unique situation.

Is Dostarlimab Better Than Pembrolizumab?

Both dostarlimab and pembrolizumab are effective PD-1 inhibitors, but they're not necessarily better or worse than each other. They work through the same mechanism but may be approved for different types of cancer or used in different treatment scenarios.

The choice between these medications often depends on factors like FDA approval for your specific cancer type, your insurance coverage, and your doctor's experience with each drug. Some patients may respond better to one medication than another due to individual differences.

Your oncologist will consider your specific cancer characteristics, medical history, and treatment goals when deciding which immunotherapy option might work best for you. The most important factor is finding the treatment that offers you the best chance of controlling your cancer while maintaining your quality of life.